Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Avdalovic, Mark
RELIANCE, NCT04069312: Roflumilast or Azithromycin to Prevent COPD Exacerbations	Recruiting	4	1250	US	Roflumilast, Daliresp, Azithromycin, Zithromax	Johns Hopkins University, Patient-Centered Outcomes Research Institute, University of Illinois at Chicago	Chronic Obstructive Pulmonary Disease Severe, Chronic Bronchitis	03/26	05/26